-
Heat spells trouble for mail-order medications
Mail-order pharmacies run well-coordinated supply chain operations to ensure medications are safely delivered to patients' doorsteps, but extreme temperatures are complicating the process, The New York Times reported Aug. 13. -
UVA Health doubles specialty pharmacy
Charlottesville, Va.-based UVA Health's specialty pharmacy has expanded its footprint at the university-owned North Fork industrial park. -
Carcinogen found in cold medicine at CVS, Walgreens
Benzene, a known carcinogen, has been discovered in Mucinex (guaifenesin) generics in CVS, Walgreens, Target and other chain stores, Bloomberg reported Aug. 12. -
Ochsner program boosts pharmacy spend, lowers overall costs
Despite rising pharmacy costs, Ochsner Health has grabbed a healthy return on investment after expanding its remote-patient monitoring program, according to an Aug. 12 article from the American Medical Association. -
Medicare drug price negotiations: 10 things to know
CMS will share its first round of negotiated Medicare drug costs by Sept. 1, though two drugmakers are still fighting the negotiations. -
FDA rejects MDMA therapy for PTSD
The FDA has rejected pharmaceutical midomafetamine (MDMA) drug therapy for the treatment of PTSD. -
Common antibiotics ranked by skin condition risks: Study
Cutaneous adverse drug reactions are a known risk of antibiotic use, but it has been unclear which drug classes carry the highest risk — until now. -
FDA calls out Bristol Myers over cancer drug claims
The FDA has accused pharmaceutical company Bristol Myers Squibb of making false or misleading claims about one of the company's cancer drug, Krazati. -
FDA approves 1st anaphylaxis nasal spray
The FDA has approved the first nasal spray to treat anaphylaxis. -
Hospitals fall short on enteral nutrition safety: ISMP
The prevalence of incorrect and expired enteral nutrition feedings is likely underreported in hospitals, according to the Institute for Safe Medication Practices. -
UNC Health launches PBM
UNC Health, a 15-hospital system based in Chapel Hill, N.C., launched a pharmacy benefit management platform Aug. 7. -
Novo Nordisk postpones Wegovy label expansion
Novo Nordisk has withdrawn its application to expand the label of Wegovy, its blockbuster weight loss medication, the company announced Aug. 7. -
Continuous glucose monitors to go OTC
After securing FDA approval, Abbott Laboratories and Dexcom will soon launch the first over-the-counter continuous glucose monitors, The Washington Post reported Aug. 5. -
UVA Health wins Premier's pharmacy award
Premier bestowed its 2024 High-Value Pharmacy Award to UVA Health, the Charlottesville, Va.-based system said in an Aug. 5 release. -
Where VP picks stand on pharmaceutical costs
JD Vance and Tim Walz, the Republican and Democratic candidates for vice president, respectively, have both voiced support for aspects of the Inflation Reduction Act, a landmark law that aims to lower prescription drug prices. -
Drugstores remodel as pharmacy deserts grow
Pharmacy owners are redesigning their stores to attract former customers who have flocked to their competitors such as Amazon, Walmart and Dollar Tree, the Chicago Tribune reported Aug. 4. -
13 online PharmD programs in the US
There are 13 fully remote, accredited doctor of pharmacy programs in the United States. -
Issues reported in MDMA therapy trials: WSJ
Three participants in trials for an experimental MDMA therapy told The Wall Street Journal their thoughts of suicide worsened during and after taking the medicine. The potential side effect was not recorded, they said. -
Emory pharmacy leader retires
Julie Temples, the director of pharmacy for information services at Emory Healthcare, is retiring. -
ASHP welcomes new president-elect
Melanie Dodd, PharmD, is now the president-elect of the American Society of Health-System Pharmacists.
Page 12 of 50